Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2010 1
2011 1
2012 3
2014 5
2015 5
2016 4
2017 4
2018 2
2019 2
2020 9
2021 7
2022 7
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC; HPTN 084 study group. Delany-Moretlwe S, et al. Among authors: ouma sg. Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
Kivuyo S, Birungi J, Okebe J, Wang D, Ramaiya K, Ainan S, Tumuhairwe F, Ouma S, Namakoola I, Garrib A, van Widenfelt E, Mutungi G, Jaoude GA, Batura N, Musinguzi J, Ssali MN, Etukoit BM, Mugisha K, Shimwela M, Ubuguyu OS, Makubi A, Jeffery C, Watiti S, Skordis J, Cuevas L, Sewankambo NK, Gill G, Katahoire A, Smith PG, Bachmann M, Lazarus JV, Mfinanga S, Nyirenda MJ, Jaffar S; RESPOND-AFRICA Group. Kivuyo S, et al. Among authors: ouma s. Lancet. 2023 Oct 7;402(10409):1241-1250. doi: 10.1016/S0140-6736(23)01573-8. Lancet. 2023. PMID: 37805215 Free article. Clinical Trial.
Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan.
Kainuma M, Kawakatsu S, Kim JD, Ouma S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: ouma s. Front Pharmacol. 2023 Jun 12;14:1203349. doi: 10.3389/fphar.2023.1203349. eCollection 2023. Front Pharmacol. 2023. PMID: 37377927 Free PMC article.
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household.
Kim S, Hesseling AC, Wu X, Hughes MD, Shah NS, Gaikwad S, Kumarasamy N, Mitchell E, Leon M, Gonzales P, Badal-Faesen S, Lourens M, Nerette S, Shenje J, de Koker P, Nedsuwan S, Mohapi L, Chakalisa UA, Mngqbisa R, Escada RODS, Ouma S, Heckman B, Naini L, Gupta A, Swindells S, Churchyard G; ACTG A5300/IMPAACT 2003 PHOENIx Feasibility Study Team. Kim S, et al. Among authors: ouma s. PLoS One. 2023 Mar 17;18(3):e0283290. doi: 10.1371/journal.pone.0283290. eCollection 2023. PLoS One. 2023. PMID: 36930628 Free PMC article.
Tryptophan catabolism reflects disease activity in human tuberculosis.
Collins JM, Siddiqa A, Jones DP, Liu K, Kempker RR, Nizam A, Shah NS, Ismail N, Ouma SG, Tukvadze N, Li S, Day CL, Rengarajan J, Brust JC, Gandhi NR, Ernst JD, Blumberg HM, Ziegler TR. Collins JM, et al. Among authors: ouma sg. JCI Insight. 2020 May 21;5(10):e137131. doi: 10.1172/jci.insight.137131. JCI Insight. 2020. PMID: 32369456 Free PMC article. Clinical Trial.
Evaluation of a tailored epilepsy training program for healthcare providers in Uganda.
Arinda A, Ouma S, Kalani K, Ramasubramanian P, Johnson T, Charles A, Newson C, Ratliff O, Kakooza-Mwesige A, Njeru P, Kaddumukasa M, Kaddumukasa M, Kolls B, Husain A, Tchapyjnikov D, Haglund M, Fuller A, Prose N, Koltai D. Arinda A, et al. Among authors: ouma s. Epilepsy Behav. 2023 Jan;138:108977. doi: 10.1016/j.yebeh.2022.108977. Epub 2022 Nov 26. Epilepsy Behav. 2023. PMID: 36446268
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: ouma s. Front Pharmacol. 2022 Oct 14;13:991982. doi: 10.3389/fphar.2022.991982. eCollection 2022. Front Pharmacol. 2022. PMID: 36313371 Free PMC article.
64 results